K. Jordan

1. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
   2017/05/05 by J.B.A.G. Haanen, John B.A.G. Haanen, Franck Carbonnel +11 · 5 citations
   Medicine · #CAR-T cell therapy research #Cancer Immunotherapy and Biomarkers #Colorectal Cancer Treatments and Studies
2. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
   2022/10/18 by John B.A.G. Haanen, J. Haanen, Michel Obéid +21 · 8 citations
   Medicine · #Cancer Immunotherapy and Biomarkers #Drug-Induced Adverse Reactions #Colorectal Cancer Treatments and Studies
3. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
   2020/10/21 by Maria‐Luisa Schubert, M.-L. Schubert, Michael Schmitt +10 · 2 citations
   Biochemistry, Genetics and Molecular Biology · Engineering · Medicine · #CAR-T cell therapy research #Nanowire Synthesis and Applications #Virus-based gene therapy research
4. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care
   2017/11/24 by Katja-Daniela Jordan, K. Jordan, Matti Aapro +23 · 1 citation
   Medicine · #Cancer survivorship and care #Childhood Cancer Survivors' Quality of Life #Palliative Care and End-of-Life Issues